Literature DB >> 3187329

Spontaneous and induced immunoglobulin synthesis and anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis: relation to leukocyte subpopulations in blood and active lesions.

N Rasmussen1, J Petersen, E Ralfkiaer, S Avnstøm, A Wiik.   

Abstract

Using a reverse plaque forming cell (PFC) assay the production of immunoglobulin (Ig) by peripheral blood mononuclear cells (MNCs) in vitro was studied in 12 patients with Wegener's granulomatosis (WG). Spontaneous IgG production was increased in two of six untreated patients. The IgG response of MNCs from eight untreated patients to pokeweed mitogen (PWM) and Epstein-Barr virus (EBV) stimulation was significantly depressed. The IgM and IgA production followed the individual pattern of IgG. Blood B-cell and T-cell subset concentrations were normal before therapy, whereas the monocyte concentration was increased in four of six patients. Titers of anti-neutrophil cytoplasm autoantibodies (ANCAs) did not correlate with spontaneous or induced Ig production nor with blood leukocyte subset concentrations. Biopsy specimens from upper respiratory tract lesions in seven untreated patients showed numerous macrophages, activated T lymphocytes, and plasma cells, suggesting a pathogenetic role of these cells in the development of lesions and local production of ANCAs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3187329     DOI: 10.1007/bf00270453

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  20 in total

1.  Wegener's granulomatosis: pathology and review of the literature.

Authors:  G C GODMAN; J CHURG
Journal:  AMA Arch Pathol       Date:  1954-12

2.  Basis for defective responses of rheumatoid arthritis synovial fluid lymphocytes to anti-CD3 (T3) antibodies.

Authors:  M Lotz; C D Tsoukas; C A Robinson; C A Dinarello; D A Carson; J H Vaughan
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

3.  Autoantibodies against cytoplasmic structures of neutrophil granulocytes in Wegener's granulomatosis.

Authors:  G Lüdemann; W L Gross
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

4.  Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis.

Authors:  C O Savage; C G Winearls; S Jones; P D Marshall; C M Lockwood
Journal:  Lancet       Date:  1987-06-20       Impact factor: 79.321

Review 5.  The normal and malignant germinal centre.

Authors:  H Stein; J Gerdes; D Y Mason
Journal:  Clin Haematol       Date:  1982-10

6.  Spontaneous and induced immunoglobulin secretion by synovial fluid B lymphocytes in rheumatoid arthritis.

Authors:  J Petersen; T Ingemann-Hansen; J S Halkjaer-Kristensen
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

7.  Suppression of human B lymphocyte function by cyclophosphamide.

Authors:  T R Cupps; L C Edgar; A S Fauci
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

8.  Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus.

Authors:  W W Ginsburg; F D Finkelman; P E Lipsky
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

9.  Production of a monoclonal antibody reactive with human dendritic reticulum cells and its use in the immunohistological analysis of lymphoid tissue.

Authors:  M Naiem; J Gerdes; Z Abdulaziz; H Stein; D Y Mason
Journal:  J Clin Pathol       Date:  1983-02       Impact factor: 3.411

10.  Clinical and immunological follow-up of patients with severe renal disease in Wegener's granulomatosis.

Authors:  I J ten Berge; J M Wilmink; C J Meyer; J Surachno; K H ten Veen; T G Balk; P T Schellekens
Journal:  Am J Nephrol       Date:  1985       Impact factor: 3.754

View more
  7 in total

Review 1.  The current status of neutrophil cytoplasmic antibodies.

Authors:  F J van der Woude; M R Daha; L A van Es
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

2.  Activated, cytotoxic lymphocytes in systemic vasculitis.

Authors:  A D Blann; D G Scott
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

Review 3.  Wegener's granulomatosis. Thoughts and observations of a pathologist.

Authors:  F Wegener
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

4.  Serum markers of T cell activation in relapses of Wegener's granulomatosis.

Authors:  C A Stegeman; J W Tervaert; M G Huitema; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

5.  Factors associated with Pneumocystis carinii pneumonia in Wegener's granulomatosis.

Authors:  B Godeau; J L Mainardi; F Roudot-Thoraval; E Hachulla; L Guillevin; L T Huong Du; B Jarrousse; P Remy; A Schaeffer; J C Piette
Journal:  Ann Rheum Dis       Date:  1995-12       Impact factor: 19.103

Review 6.  Mechanisms of endothelial cell injury in vasculitis.

Authors:  A A Pall; C O Savage
Journal:  Springer Semin Immunopathol       Date:  1994

Review 7.  Update on pathogenic mechanisms of systemic necrotizing vasculitis.

Authors:  Maria I Danila; S Louis Bridges
Journal:  Curr Rheumatol Rep       Date:  2008-12       Impact factor: 4.592

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.